2017
DOI: 10.5301/hipint.5000578
|View full text |Cite
|
Sign up to set email alerts
|

Up to 10-year follow-up of the Symax stem in THA: a Danish single-centre study

Abstract: From the Danish Hip Arthroplasty Registry, we identified the overall 6.5-year survival rate to be 95% for cementless THAs. In the present study, the Symax stem has a median 6.5-year survival rate at 97.5% (96.6%-98.3%). No revisions were due to aseptic loosening but the stem had a relative high prevalence of periprosthetic fractures.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
6
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(7 citation statements)
references
References 16 publications
0
6
1
Order By: Relevance
“…The cohorts of patients of both previously mentioned studies were independent. Furthermore, a Danish single-center registry study of the Symax hip stem showed a median 6.5-year survival rate of 97.5% (95% CI 96.6-98.3%), while the overall median 6.5-year survival rate for uncemented hip stems was 95% in the same Danish registry (Edwards et al 2018). In this registry study with follow-up of up to 10 years, 29 of 1,055 hip stems were revised.…”
Section: Discussionmentioning
confidence: 65%
“…The cohorts of patients of both previously mentioned studies were independent. Furthermore, a Danish single-center registry study of the Symax hip stem showed a median 6.5-year survival rate of 97.5% (95% CI 96.6-98.3%), while the overall median 6.5-year survival rate for uncemented hip stems was 95% in the same Danish registry (Edwards et al 2018). In this registry study with follow-up of up to 10 years, 29 of 1,055 hip stems were revised.…”
Section: Discussionmentioning
confidence: 65%
“…Our study population was comparable to the total group of patients with uncemented THAs in the Netherlands for age, gender distribution, and diagnosis. The cumulative revision rates are also in line with the median 6.5-year survival rates of the Symax hip stem with all-cause revision as the endpoint of 97.5% (96.6%-98.3%) in Vejle, Denmark [8]. The NICE recommends only those hip prostheses which have (projected) revision rates of 5% or less at 10-year clinical follow-up [12].…”
Section: Plos Onementioning
confidence: 70%
“…The stem showed early stabilization in 2 independent RSA studies, and excellent clinical outcomes in a 5-year clinical and radiographic follow-up study [5][6][7]. In a Danish implant registry study that included 1,055 total hip arthroplasties (THAs) in a single centre, the estimated 6.5-year survival rate of the Symax hip stem with all-cause revision as the endpoint was 97.5% (CI 96.6%-98.3%) [8]. Most common reasons for revision surgery in that study were periprosthetic fractures (n = 11) and recurrent dislocations (n = 10) [8].…”
Section: Introductionmentioning
confidence: 99%
“…Clinical studies have looked at different surgical approaches, 19 interface conditions, 20 and commercially available stem designs having different geometries, sizes, coatings, and materials. 6,17,[19][20][21][22][23][24][25][26][27][28][29][30][31] Only a few of these studies report on both tapered and cylindrical cementless implant designs for use in more challenging revision THA procedures. 6,17,23,31 From these remaining studies, different implant manufacturers were used and therefore different overall stem designs were tested.…”
mentioning
confidence: 99%
“…Despite clinical success of each of these stem designs and their wide adoption, 6,17,19,20,23,[25][26][27][28][29][30][31] a direct mechanical comparison between cylindrical and tapered stems, controlling for distal taper as a singled out implant design variable, with more severe Type III-B bone defects is lacking in the literature. Experimental studies have tested cylindrical 32,33 and compared tapered with cylindrical THA stem designs with both Type III-A 7,34 and Type III-B bone defects.…”
mentioning
confidence: 99%